Publikationen

Koristka, S., A. Kegler, R. Bergmann, C. Arndt, A. Feldmann, S. Albert, M. Cartellieri, A. Ehninger, G. Ehninger, J. M. Middeke, M. Bornhauser, M. Schmitz, J. Pietzsch, K. Akgun, T. Ziemssen, J. Steinbach and M. P. Bachmann (2018). "Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology." J Autoimmun 90: 116-131.

Bachmann, D., R. Aliperta, R. Bergmann, A. Feldmann, S. Koristka, C. Arndt, S. Loff, P. Welzel, S. Albert, A. Kegler, A. Ehninger, M. Cartellieri, G. Ehninger, M. Bornhauser, M. von Bonin, C. Werner, J. Pietzsch, J. Steinbach and M. Bachmann (2018). "Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells." Oncotarget 9(7): 7487-7500.

Albert, S., C. Arndt, A. Feldmann, R. Bergmann, D. Bachmann, S. Koristka, F. Ludwig, P. Ziller-Walter, A. Kegler, S. Gartner, M. Schmitz, A. Ehninger, M. Cartellieri, G. Ehninger, H. J. Pietzsch, J. Pietzsch, J. Steinbach and M. Bachmann (2017). "A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform." Oncoimmunology 6(4): e1287246.

Feldmann, A., C. Arndt, R. Bergmann, S. Loff, M. Cartellieri, D. Bachmann, R. Aliperta, M. Hetzenecker, F. Ludwig, S. Albert, P. Ziller-Walter, A. Kegler, S. Koristka, S. Gartner, M. Schmitz, A. Ehninger, G. Ehninger, J. Pietzsch, J. Steinbach and M. Bachmann (2017). "Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"." Oncotarget 8(19): 31368-31385.

Mitwasi, N., A. Feldmann, R. Bergmann, N. Berndt, C. Arndt, S. Koristka, A. Kegler, J. Jureczek, A. Hoffmann, A. Ehninger, M. Cartellieri, S. Albert, C. Rossig, G. Ehninger, J. Pietzsch, J. Steinbach and M. Bachmann (2017). "Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells." Oncotarget 8(65): 108584-108603.

Bejestani, E. P., M. Cartellieri, R. Bergmann, A. Ehninger, S. Loff, M. Kramer, J. Spehr, A. Dietrich, A. Feldmann, S. Albert, M. Wermke, M. Baumann, M. Krause, M. Bornhauser, G. Ehninger, M. Bachmann and M. von Bonin (2017). "Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model." Oncoimmunology 6(10): e1342909.

Cartellieri, M., A. Feldmann, S. Koristka, C. Arndt, S. Loff, A. Ehninger, M. von Bonin, E. P. Bejestani, G. Ehninger and M. P. Bachmann (2016). "Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts." Blood Cancer J 6(8): e458.

Cartellieri, M., M. Bachmann, A. Feldmann, C. Bippes, S. Stamova, R. Wehner, A. Temme and M. Schmitz (2010). "Chimeric antigen receptor-engineered T cells for immunotherapy of cancer." J. Biomed. Biotechnol 2010:956304. Epub;%2010 May 5.: 956304.

 

Meeting Presentations UniCAR technology (Selection)

Dietrich, J., J. Riewaldt, S. Loff, J.E. Meyer, S. Schallenberg, Spehr, J., Gründer, C., Franke, K., Kreissig, C., Ehninger, G., Bachmann, M., Ehninger, A., and Cartellieri, M. (2018). „Clinical-grade manufacturing of switchable CAR-T cells in an automated closed system for phase I/II trials” ISCT 2018 Montreal Annual Meeting.

Dietrich, J., Loff, S., Meyer, J.E., , von Bonin, M., Hetzenecker, M., Spehr, J., Gründer, C., Riewaldt, J., Ehninger, G., Bachmann, M., Ehninger, A., and Cartellieri, M. (2017). Targeting Leukemia using an inducible universal chimeric antigen receptor (UniCAR) T cell technology.” ISCT 2017 London Annual Meeting. Cytotherapy 19,(5).

Ehninger, A., Cartellieri, M., Arndt, C., Feldmann, A., Koristka, S., Loff, S., von Bonin, M., Ehninger, G. and Bachmann, M. (2016): Improved killing of tumor cells by a novel flexible antibody-based modular T cell retargeting system. AACR Annual Meeting 2016, New Orleans, US.

Cartellieri, M., Loff, S., von Bonin, M., Bejestani, E.P., Ehninger, A., Feldmann, A., Koristka, S., Arndt, C., Ehninger, G. and Bachmann, M. (2015) UniCAR: A Novel Modular Retargeting Platform Technology for CAR T Cells. 2015,  Blood Abstract (presented at ASH 2015, Orlando, US) 126:5549.

Cartellieri M., Loff S., von Bonin M., Bejestani E.P., Ehninger A., Feldmann A., Koristka S., Arndt C.,  Ehninger G. and Bachmann M. (2015). A novel modular retargeting platform technology for precise control of CAR T cell reactivity. CIMT 2015, Mainz, Germany (poster award winner).

Koristka, S., Cartellieri, M., Feldmann, A., Arndt, C., Loff, S., Michalk, I., Aliperta, R., von Bonin, M., Bornhäuser, M., Ehninger, A., Ehninger, G. and Bachmann, M. (2014). Flexible Antigen-Specific Redirection of Human Regulatory T Cells Via a Novel Universal Chimeric Antigen Receptor System. Blood Abstract (presented at ASH 2014, Washington, US) 124:3494.